Wells Fargo Preview: Why I'm Buying Before Earnings

Wells Fargo's 2026 EPS estimates have risen more than 5% over the past 90 days despite sharp share-price underperformance. Management now expects Q3 net interest margin to be roughly flat to down 1 basis point sequentially, an improvement from earlier guidance; net interest income is still expected to grow, supported by loan growth, securities reinvestment and post-asset-cap balance-sheet expansion.

Analysis

The setup is a potential expectations gap, not yet proof of an earnings inflection: estimate upgrades alongside a weak share price can support a catch-up trade, but the market may be discounting whether incremental balance-sheet growth earns an adequate return. A better NIM trajectory matters most if it reflects durable asset yields and stable deposit pricing; loan growth and securities reinvestment can lift NII while funding costs, credit costs, operating expenses, or capital needs dilute the benefit. Post-cap growth also makes the quality of new assets and the pace of risk-weighted-asset accumulation more important than headline balance-sheet expansion.

Near term, Q3 NIM is the observable catalyst, but the bar is the market’s embedded expectation—not merely management’s improved guidance. Over 1–3 months, watch reported NII versus consensus, deposit costs/beta, loan growth and credit trends. Over 6–18 months, the thesis depends on whether growth converts into stronger returns on capital without renewed regulatory constraints or weaker underwriting. The contrarian angle is that price weakness may reflect doubts about conversion and execution rather than a failure of current-year EPS estimates; conversely, estimate revisions may already leave little room for a clean beat. No valuation, current consensus detail, or deposit/credit data were supplied, so conviction and payoff cannot be quantified.

Key Decisions for Investors

• Consider a modest, event-sized long WFC versus a broad bank ETF such as KBE ahead of Q3 only if WFC’s relative underperformance persists and estimates remain stable. This expresses a catch-up thesis while limiting broad-sector exposure; avoid sizing it as a durable earnings rerating until NII and returns on incremental assets confirm the mechanism.
• Treat Q3 as a confirmation test: favor the position if NIM is at or better than the guided range and NII growth is accompanied by stable deposit costs and credit quality. Reduce or exit if NIM undershoots, NII misses despite balance-sheet growth, or credit deterioration/expense growth absorbs the revenue benefit.
• Before adding, verify current valuation versus bank peers, the market-implied NIM/NII bar, deposit mix and pricing, and the pace and capital intensity of post-cap growth. These missing inputs determine whether the apparent estimate/price disconnect is mispricing or justified skepticism.
• Risk framework: near-term upside is a relief-driven relative rebound; downside is renewed underperformance if the quarter exposes weak funding economics or poor growth conversion. Do not assign a price target from the supplied information.